Doctor profile · Federal record
Dr. Rebecca Eng, ARNP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Kennewick, WA
- NPI 1265661342
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 17 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8901 W Gage Blvd
Kennewick, WA 99336
(509) 735-1100
fax (509) 735-1180
Credentials & registration
- NPI registered
- July 2009 — 17 yrs on file
- Profile last updated
- July 31, 2013
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Washington #AP60086708
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265661342. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,266
Distinct HCPCS
10
Medicare allowed
$388,493
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,229 | 661 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,287 | 909 | $77 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,147 | 807 | $41 | |
11102 |
Biopsy of related skin growth, first growth | 699 | 578 | $79 | |
17110 |
Destruction of skin growth, 1-14 growths | 465 | 384 | $97 | |
11103 |
Biopsy of related skin growth, each additional growth | 312 | 229 | $43 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 249 | 178 | $107 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 191 | 139 | $146 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | 45 | $1 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 98 | 94 | $48 |
In context: peer comparison
Among 13 peers in Kennewick Family Nurse Practitioner, average services per provider: 177. This provider delivers 52× the peer median.Open Payments
Industry payments received
All-time total
$1,780
Transactions
97
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 30 | $455.91 | |
| Janssen Biotech, INC. | 20 | $246.56 | |
| Lilly USA, LLC | 12 | $237.67 | |
| E.R. Squibb & Sons, L.L.C. | 11 | $179.23 | |
| Regeneron Healthcare Solutions, INC. | 4 | $157.29 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 3 | $91.97 | |
| Sanofi-Aventis U.S. LLC | 1 | $89.95 | |
| Genzyme Corporation | 2 | $67.13 | |
| Novartis Pharmaceuticals Corporation | 3 | $62.72 | |
| Ucb, INC. | 3 | $54.06 | |
| Pfizer INC. | 3 | $49.89 | |
| Galderma Laboratories, L.P. | 2 | $35.10 | |
| Arcutis Biotherapeutics, INC. | 2 | $30.05 | |
| Amgen INC. | 1 | $22.79 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
526
Patients
228
Total drug cost
$14,771
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 167 | 93 | $2,001 |
| Ketoconazole | Generic | 72 | 42 | $1,429 |
| Clobetasol Propionate | Generic | 54 | 29 | $3,019 |
| Fluconazole | Generic | 34 | 12 | $238 |
| Doxycycline Hyclate | Generic | 32 | 16 | $462 |
| Metronidazole | Generic | 30 | 20 | $2,667 |
| Mupirocin | Generic | 30 | 16 | $342 |
| Gabapentin | Generic | 24 | 0 | $324 |
| Betamethasone Dipropionate | Generic | 13 | 0 | $982 |
| Fluorouracil | Generic | 13 | 0 | $1,911 |
Frequently asked questions
What is Dr. Rebecca Eng's medical specialty?
Dr. Rebecca Eng practices Family Nurse Practitioner in Kennewick, WA.
Where does Dr. Rebecca Eng practice?
Dr. Rebecca Eng practices at 8901 W Gage Blvd, Kennewick, WA 99336. Office phone: 5097351100.
What is Dr. Rebecca Eng's NPI?
Dr. Rebecca Eng's National Provider Identifier (NPI) is 1265661342, issued by NPPES.
Does Dr. Rebecca Eng accept Medicare assignment?
Yes. Dr. Rebecca Eng accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rebecca Eng commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.